A promising inactivated whole-virion SARS-CoV-2 vaccine.

Isakova-Sivak, Irina; Rudenko, Larisa

Isakova-Sivak, Irina; Rudenko, Larisa.

Isakova-Sivak I; Institute of Experimental Medicine, Saint Petersburg 197376, Russia.
Rudenko L; Institute of Experimental Medicine, Saint Petersburg 197376, Russia. Electronic address: vaccine@mail.ru.

Lancet Infect Dis ; 21(1): 2-3, 2021 01.

Article in English | MEDLINE | ID: covidwho-863715

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/prevention & control; SARS-CoV-2/immunology; Virion/immunology; Adolescent; Adult; Aged; COVID-19 Vaccines/adverse effects; Clinical Trials as Topic; Humans; Middle Aged; Vaccines, Inactivated/immunology; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virion / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(20)30832-X

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google